
How do we track guidance changes and stay submission-ready with a small team? A complete, step-by-step guide to a
regulatory-intelligence and AI submission-readiness platform for biotech regulatory affairs teams — continuous FDA
guidance monitoring, an explainable, human-reviewed submission audit, PDUFA deadline tracking, the full AI
architecture, pricing model, and go-to-market plan. Positioned strictly as decision-support — it never predicts or
guarantees FDA approval.
THE PROOF
19 Complete Response Letters issued across 2025 (SinoDrugWatch analysis of published FDA
CRLs)
WHAT IT SETTLES
Stay Ahead of FDA Guidance and Deadlines.